This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Discontinuance Of Quarterly Cash Dividend And Share Repurchase Program By American Physicians Capital, Inc. Is Being Investigated By The Law Office Of Joseph Klein- ACAP

The Law Office of Joseph Klein is investigating the Board of Directors of American Physicians Capital Inc. (“AP Capital” or the “Company”) (NasdaqGS: ACAP) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to The Doctors Company ("Doctors Company"). Under the terms of the transaction, AP Capital shareholders will receive $41.50 in cash for each AP Capital share of common stock they own for a total transaction value of approximately $386 million. Importantly, the terms of the proposed transaction prohibit AP Capital from paying dividends or repurchasing its shares without the prior consent of Doctors Company, and AP Capital has declared that it does not intend to seek permission to pay any further cash dividends to its shareholders or to continue its share repurchase program.

The investigation focuses on whether the AP Capital Board of Directors breached their fiduciary duties to AP Capital stockholders by failing to adequately shop the Company before entering into this transaction and whether Doctors Company is underpaying for AP Capital shares, thus unlawfully harming AP Capital stockholders. The investigation further seeks to determine whether the Board’s discontinuance of AP Capital’s cash dividend and share repurchase program unlawfully harmed AP Capital’s shareholders.

If you own AP Capital shares and wish to obtain additional information about this investigation and what is being done to advance the shareholders’ interests, please contact Joseph Klein, Esq. directly, via email at, by telephone at (718) 947-0005 or

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $117.81 0.00%
FB $105.45 0.00%
GOOG $750.26 0.00%
TSLA $231.61 0.00%
YHOO $32.94 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs